Thermo Fisher TMO

HealthcareMarket cap $220B11 connections

Thermo Fisher Scientific makes the instruments, reagents, and services that power life science research - mass spectrometers, PCR machines, cell culture media, and genetic analysis tools. Its 100,000+ products are used in every pharmaceutical lab, hospital, and research institution. COVID accelerated demand for its PCR reagents. Its pharma services (outsourced drug manufacturing) is its fastest-growing division.

Explore Thermo Fisher on the interactive map Relationship timeline Find a path to another company

Customers 7

Companies Thermo Fisher sells to

Eli LillyHealthcare · $700BBioprocessing & analytical equipment
AbbVieHealthcare · $320BLab tools for biologics
MerckHealthcare · $290BAnalytical instruments for R&D
PfizerHealthcare · $160BLab equipment for drug manufacturing
HCA HealthcareHealthcare · $85BThermo Fisher lab equipment in HCA facilities
ModernaHealthcare · $45BmRNA manufacturing equipment
BioMarin PharmaHealthcare · $15BThermo Fisher supplies BioMarin gene therapy tools

Competitors 4

Companies it competes with

Agilent TechnologiesHealthcare · $27BLab instruments
RevvityHealthcare · $11BLife science tools
Bio-TechneHealthcare · $10BResearch reagents
Bio-Rad LaboratoriesHealthcare · $8BLife science tools

Other Healthcare companies

Eli Lilly UnitedHealth Novo Nordisk Johnson & Johnson AbbVie Merck AstraZeneca Novartis Abbott Labs Roche Holding

Embed this on your site

Show Thermo Fisher's network in an article or report - it updates as our data does.

<iframe src="https://vexmap.com/embed.html?co=TMO" width="600" height="420" style="border:0;border-radius:12px;max-width:100%" title="Thermo Fisher on VexMap" loading="lazy"></iframe>

Preview

Relationships are compiled by VexMap from company filings, announcements and reporting, and last reviewed September 2026. Spotted something wrong? Tell us. Not investment advice.